Showing results (551-560 of 735) with videos related to
Sort By:
Pageof 74
Cancer Cell|April 10, 2023
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanomaKatie M Campbell, Meelad Amouzgar, Shannon M Pfeiffer, et al.European Journal of Cancer (Oxford, England : 1990)|March 28, 2024
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanomaJoseph J Sacco, Richard Jackson, Pippa Corrie, et al.Cancer Cell|February 24, 2023
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancerBalaji Virassamy, Franco Caramia, Peter Savas, et al.Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.Nature Communications|December 17, 2024
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomographyHannah E Greenwood, Abigail R Barber, Richard S Edwards, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionFabio Conforti, Laura Pala, Eleonora Pagan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 11, 2021
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, Philip Mack, Giorgio V Scagliotti, et al.Nature Medicine|August 7, 2015
Toward understanding and exploiting tumor heterogeneityAsh A Alizadeh, Victoria Aranda, Alberto Bardelli, et al.Nature Communications|January 4, 2019
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.European Urology Focus|February 11, 2019
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted TherapyPeter E Hall, Scott T C Shepherd, Janet Brown, et al.Pageof 74